Mechanisms of retinoid resistance in leukemic cells: Possible role of cytochrome P450 and P-glycoprotein

Blood

Volumn 87, Issue 2, 1996, Pages 725-733

  Kizaki, Masahiro ^a   Ueno, Hironori ^b   Yamazoe, Yasushi ^b   Shimada, Miki ^b   Takayama, Nobuyuki ^b   Muto, Akihiro ^b   Matsushita, Hiromichi ^b   Nakajima, Hideaki ^b   Morikawa, Minoru ^b   Koeffler, H Phillip ^b   Ikeda, Yasuo ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; RETINOIC ACID; VERAPAMIL;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER REGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; DRUG CLEARANCE; DRUG METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 13344295088     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.2.725.bloodjournal872725     Document Type: Article

References (42)

1. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 605:33, 1980
2. Sporn MB, Roberts AB: Role of retinoids in differentiation and carcinogenesis. Cancer Res 43:3034, 1983
3. Merriman R, Bertram J: Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/ 10T-clone 8 cells. Cancer Res 39:1661, 1979
4. Strickland S, Mahdavi M: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393, 1978
5. Douer D, Koeffler HP: Retinoic acid; inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest 69:277, 1982
6. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936, 1980
7. Koeffler HP: Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implications. Blood 62:709, 1983
8. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu HT, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
9. Castaigne S, Chomienne C, Daniel MT, Ballarini P, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
10. Warrell RP Jr, Frankel SR, Miller WH Jr, Sheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovski E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
11. Warrell RP Jr, de The H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
12. Kizaki M, Nakajima H, Mori S, Koike T, Morikawa M, Ohta M, Saito M, Koeffler HP, Ikeda Y: Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. Blood 83:3289, 1994
13. Muindi JF, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovski E, Warrell RP Jr: Continuous treatment with all-trans retinoic acid causes a progressive decrease in plasma concentrations: Implications for relapse and "resistance" in acute promyelocytic leukemia. Blood 79:299, 1992
14. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82:1949, 1993
15. Roberts AB, Lamb LC, Sporn MB: Metabolism of all-trans retinoic acid in hamster liver microsomes: Oxidation of 4-hydroxy-to 4-keto retinoic acid. Arch Biochem Biophys 199:374, 1980
16. Chen C, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381, 1986
17. Hamada H, Tsuruo T: Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785, 1986
18. Deruyter MG, Lambert WE, Deleenheer AP: Retinoic acid: An endogenous compound of human blood. Unequivocal demonstration of endogenous retinoic acid in normal physiological conditions. Anal Biochem 98:402, 1979
19. Gallagher RE, Bilello PA, Ferrari AC, Chang CS, Yen RWC, Nickols WA, Muly EM III: Characterization of differentiation inducer-resistant HL-60 cells. Leuk Res 9:967, 1985
20. Arkin H, Ohnuma T, Kamen BA, Holland JF, Vollabhajosula S: Multidrug resistance in a human leukemia cell line selected for resistance to trimetrexate. Cancer Res 49:6556, 1989
21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162:156, 1987
22. 3 receptor RNA: Expression in hematopoietic cells. Blood 77:1238, 1991
23. Watt R, Stanton LW, Marcu KB, Gallo RC, Croce CM, Rovera G: Nucleotide sequence of cloned cDNA of human c-myc oncogene. Nature 303:725, 1983
24. Koike T, Harada N, Yoshida T, Morikawa M: Regulation of myeloid-specific calcium binding protein synthesis by cytosolic protein kinase C. J Biochem 112:624, 1992
25. Ponte P, Gunning P, Blau H, Kedes L: Human actin genes are single copy of alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3′-untranslated regions are isotype specific but conserved in evolution. Mol Cell Biol 3:1783, 1983
26. Jaiswal AK, Gonzalez FJ, Nebert DW: Human-inducible cytochrome P1-450: Complementary DNA and amino acid sequence. Science 228:80, 1985
27. Ponte P, Ng S-Y, Engel J, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of actin mRNA: DNA sequence of human beta-actin cDNA. Nucleic Acids Res 12:1687, 1984
28. Kamataki T, Maeda K, Shimada M, Kitani K, Nagai T, Kato R: Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats. J Pharmacol Exp Ther 233:222, 1985
29. Wiebel FJ, Gelboin HV: Aryl hydrocarbon (benze[a]pyren) hydroxylases in liver from rats of different age, sex and nutritional status. Biochem Pharmacol 24:1511, 1975
30. Roberts EA, Johnson KC, Harper PA, Okey AB: Characterization of the Ah receptor mediating aryl hydrocarbon hydroxylase induction in the human liver cell line Hep G2. Arch Biochem Biophys 276:442, 1990
31. Robertson KA, Emai B, Collins SJ: Retinoic acid-resistant HL-60 cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity Blood 80:1885, 1992
32. Li YP, Said F, Gallagher RE: Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-α. Blood 83:3298, 1994
33. Muindi JF, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW, Warrell RP Jr: Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52:2138, 1992
34. Delva L, Monique C, Balitrand N, Guidez F, Miclea J-M, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, Chomienne C: Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular RA binding protein levels in leukemic cells. Blood 82:2175, 1993
35. Rigas JR, Francis PA, Muindi JF, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP Jr: Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans retinoic acid, and its modulation by ketoconazole. J Natl Cancer Inst 85:1921, 1993
36. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K, Nebert DW: The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1, 1993
37. Vecchini F, Lenoir-Viale MC, Cathelineau C, Magdalou J, Bernard BA, Shroot B: Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem Biophys Res Commun 201:1205, 1994
38. Muindi JF, Young CW: Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms. Cancer Res 53:1226, 1993
39. Muindi JF, Scher HI, Rigas JR, Warrell RP Jr, Young CW: Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans retinoic acid in patients with advanced cancer. Cancer Res 54:2125, 1994
40. Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Grever M, Bates S, Fojo T: Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the national cancer institute anticancer drug screen. J Clin Invest 95:2205, 1995
41. Paietta E, Andersen J, Racevski J, Gallagher R, Bennett J, Yunis J, Cassileth P, Wiernik PH: Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: Immunological, molecular and functional analyses. Leukemia 8:968, 1994
42. Drach D, Zhao S, Drach J, Andreeff M: Low incidence of MDR1 expression in acute promyelocytic leukemia. Br J Haematol 90:369, 1995